K103N mutation in antiretroviral therapy-naive African patients infected with HIV type 1

被引:4
作者
Akinsete, O
Hirigoyen, D
Cartwright, C
Schut, R
Kantor, R
Henry, K
机构
[1] Univ Minnesota, Dept Infect Dis, Hennepin Cty Med Ctr, Minneapolis, MN 55455 USA
[2] Stanford Univ, Dept Med, Div Infect Dis, Palo Alto, CA 94304 USA
[3] Stanford Univ, Ctr AIDS Res, Palo Alto, CA 94304 USA
关键词
D O I
10.1086/422519
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Most of the information about genetic sequencing and drug susceptibility of human immunodeficiency virus type 1 (HIV-1) is derived from the study of HIV-1 subtype B. Worldwide, most people infected with HIV-1 are infected with non-subtype B viruses and live in developing countries. We report 3 cases of antiretroviral-naive African immigrants infected with HIV-1 strains possessing the K103N mutation in the reverse transcriptase gene, which confers high-level resistance to all nonnucleoside reverse transcriptase inhibitors.
引用
收藏
页码:575 / 578
页数:4
相关论文
共 16 条
[1]  
Adjé C, 2001, J ACQ IMMUN DEF SYND, V26, P501, DOI 10.1097/00126334-200104150-00018
[2]  
BOLLYKY PL, 2002, 14 INT AIDS C BARC B, V1, P475
[3]  
D'Aquila Richard T, 2003, Top HIV Med, V11, P92
[4]   Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012) [J].
Eshleman, SH ;
Mracna, M ;
Guay, LA ;
Deseyve, M ;
Cunningham, S ;
Mirochnick, M ;
Musoke, P ;
Fleming, T ;
Fowler, MG ;
Mofenson, LM ;
Mmiro, F ;
Jackson, JB .
AIDS, 2001, 15 (15) :1951-1957
[5]  
Eshleman Susan H., 2002, AIDS Reviews, V4, P59
[6]   Extended spectrum of HIV-1 reverse transcriptase mutations in patients receiving multiple nucleoside analog inhibitors [J].
Gonzales, MJ ;
Wu, TD ;
Taylor, J ;
Belitskaya, F ;
Kantor, R ;
Israelski, D ;
Chou, S ;
Zolopa, AR ;
Fessel, WJ ;
Shafer, RW .
AIDS, 2003, 17 (06) :791-799
[7]   Human immunodeficiency virus type 1 reverse-transcriptase and protease subtypes: Classification, amino acid mutation patterns, and prevalence in a northern California clinic-based population [J].
Gonzales, MJ ;
Machekano, RN ;
Shafer, RW .
JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (08) :998-1006
[8]   Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1:: 2003 recommendations of an international AIDS Society-USA panel [J].
Hirsch, MS ;
Brun-Vézinet, F ;
Clotet, B ;
Conway, B ;
Kuritzkes, DR ;
D'Aquila, RT ;
Demeter, LM ;
Hammer, SM ;
Johnson, VA ;
Loveday, C ;
Mellors, JW ;
Jacobsen, DM ;
Richman, DD .
CLINICAL INFECTIOUS DISEASES, 2003, 37 (01) :113-128
[9]  
KANTOR R, 2002, 9 RETR OPP INF SEATT, P343
[10]   Antiretroviral-drug resistance among patients recently infected with HIV [J].
Little, SJ ;
Holte, S ;
Routy, JP ;
Daar, ES ;
Markowitz, M ;
Collier, AC ;
Koup, RA ;
Mellors, JW ;
Connick, E ;
Conway, B ;
Kilby, M ;
Wang, L ;
Whitcomb, JM ;
Hellmann, NS ;
Richman, DD .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (06) :385-394